Chloe Orkin
speaker
8 appearances
1 recordings
1 series
first heard Feb 2026
last heard 27 Feb
Chloe Orkin’s voice in public audio — every appearance, attributed to the second.
Trend
recordings per month · last 12 monthsRecordings per month over the last 12 months — 1 in all, peaking in Feb 2026 with 1.
Appearances
Most people living with HIV can take a single daily pill or injections every two months, but many long-time HIV survivors who were put on early drugs developed resistance, so they must take many pills multiple times a day.
Now, a new pill made by Gilead Sciences may mean they can simplify their treatment regimen.
Chloe Orkin of Queen Mary University of London co-authored the study.
The particular pill
excitement is for this population who's been left behind by medical advances.
This new daily pill combines two drugs and appears to be as effective as the complex treatments.
Orkin says the drug could be available in many countries within a year.
Gabriela Emanuel, NPR News.
Showing 1–8 of 8